Subsequent Events – Agreement to Sell Assets of Clinical Labs Division to Labcorp (Details) |
6 Months Ended |
|---|---|
|
Jan. 31, 2023
USD ($)
| |
| Subsequent Events [Abstract] | |
| Cash | $ 146,000,000 |
| Shares outstanding rate | 11.00% |
| Termination fee | $ 5,000,000 |
| Reimbursement of buyer’s expenses | $ 5,000,000 |
| X | ||||||||||
- Definition Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A payment from an investee, in which the investment basis has previously been reduced to zero. This amount reduces net cash used in operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase from purchase of security purchased under agreement to resell. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|